Home / Inspections / 1321372

FDA Inspection 1321372 — Fisher Clinical Services, Inc.

Fisher Clinical Services, Inc. — FEI 2529019

The FDA completed an inspection of Fisher Clinical Services, Inc. on May 7, 2026 in Allentown, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 7, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allentown, PA (United States)

Facility

Other inspections at this facility

  • 1271507 (NAI Wed May 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1209413 (NAI Thu Jun 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027720 (NAI Thu Aug 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 991558 (NAI Fri Oct 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 753113 (NAI Wed Nov 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources